Curian Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-40,582
Closed -$1.74M 238
2015
Q4
$1.74M Sell
40,582
-220,594
-84% -$9.7M 0.13% 170
2015
Q3
$11M Sell
261,176
-129,041
-33% -$6.03M 0.29% 78
2015
Q2
$19.5M Buy
390,217
+795
+0.2% +$37.6K 0.33% 68
2015
Q1
$17.5M Buy
389,422
+8,698
+2% +$391K 0.29% 79
2014
Q4
$18.4M Buy
380,724
+31,443
+9% +$1.49M 0.31% 72
2014
Q3
$16.7M Buy
349,281
+16,427
+5% +$798K 0.3% 78
2014
Q2
$16.5M Buy
332,854
+193,844
+139% +$9.07M 0.29% 81
2014
Q1
$6.54M Buy
139,010
+23,930
+21% +$1.1M 0.12% 199
2013
Q4
$5.53M Buy
115,080
+3,270
+3% +$147K 0.1% 204
2013
Q3
$4.68M Buy
111,810
+101,127
+947% +$4.36M 0.08% 208
2013
Q2
$436K Buy
+10,683
New +$393K 0.01% 506

Other funds holding MET

Curian Capital's MET Position: Q1 2016 in Review

Curian Capital sold out of MetLife (MET) in Q1 2016, closing a stake of 40,582 shares — an estimated $1.74M sold.

Curian Capital first reported a position in MET in Q2 2013 and held it in 11 quarters. The position peaked at $19.5M in Q2 2015. 970 funds tracked by Wall St. Rank hold MET as of Q1 2016.

  • Curian Capital reported no remaining MetLife position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 40,582 MetLife shares in Q1 2016, an estimated $1.74M.
  • Curian Capital first reported a position in MetLife in Q2 2013 and held it in 11 quarters.
  • Curian Capital's MetLife position peaked at $19.5M in Q2 2015.
  • 970 funds tracked by Wall St. Rank held MetLife as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.